Hear how Cambrian BioPharma is reinventing drug (and drug company) development

Hear how Cambrian BioPharma is reinventing drug (and drug company) development

a year ago
Anonymous $QMjB47b2Hv

https://techcrunch.com/2023/05/01/hear-how-cambrian-biopharma-is-reinventing-drug-and-drug-company-development/

I’m thrilled to announce this TechCrunch Live event. The startup Cambrian BioPharma is developing a life-changing technology while pioneering a radical approach to a pharmaceutical company. Don’t miss this TechCrunch Live taking place on May 3 at 12 p.m. PDT. Register here. It’s free to watch and participate.

Cambrian BioPharma bills itself as a new pharmaceutical company with a revolutionary approach to developing and managing drug development. James Peyer, PhD, co-founded the company in 2019, and it has since raised over $180 million to accelerate the development of medicine designed to target the causes of age-related diseases.

Hear how Cambrian BioPharma is reinventing drug (and drug company) development

May 1, 2023, 4:19pm UTC
https://techcrunch.com/2023/05/01/hear-how-cambrian-biopharma-is-reinventing-drug-and-drug-company-development/ > I’m thrilled to announce this TechCrunch Live event. The startup Cambrian BioPharma is developing a life-changing technology while pioneering a radical approach to a pharmaceutical company. Don’t miss this TechCrunch Live taking place on May 3 at 12 p.m. PDT. Register here. It’s free to watch and participate. > Cambrian BioPharma bills itself as a new pharmaceutical company with a revolutionary approach to developing and managing drug development. James Peyer, PhD, co-founded the company in 2019, and it has since raised over $180 million to accelerate the development of medicine designed to target the causes of age-related diseases.